273 related articles for article (PubMed ID: 28695501)
21. Lactate down-regulates cellular poly(ADP-ribose) formation in cultured human skin fibroblasts.
Wagner S; Hussain MZ; Beckert S; Ghani QP; Weinreich J; Hunt TK; Becker HD; Königsrainer A
Eur J Clin Invest; 2007 Feb; 37(2):134-9. PubMed ID: 17217379
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
23. Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1.
Pic E; Gagné JP; Poirier GG
Expert Rev Proteomics; 2011 Dec; 8(6):759-74. PubMed ID: 22087659
[TBL] [Abstract][Full Text] [Related]
24. Regulation of poly ADP-ribosylation of VEGF by an interplay between PARP-16 and TNKS-2.
Kunhiraman H; Ramachandran V; Edatt L; Sameer Kumar VB
Mol Cell Biochem; 2020 Aug; 471(1-2):15-27. PubMed ID: 32472322
[TBL] [Abstract][Full Text] [Related]
25. Large-scale preparation and characterization of poly(ADP-ribose) and defined length polymers.
Tan ES; Krukenberg KA; Mitchison TJ
Anal Biochem; 2012 Sep; 428(2):126-36. PubMed ID: 22743307
[TBL] [Abstract][Full Text] [Related]
26. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation.
Gibson BA; Zhang Y; Jiang H; Hussey KM; Shrimp JH; Lin H; Schwede F; Yu Y; Kraus WL
Science; 2016 Jul; 353(6294):45-50. PubMed ID: 27256882
[TBL] [Abstract][Full Text] [Related]
27. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
Tramontano F; Malanga M; Quesada P
Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
[TBL] [Abstract][Full Text] [Related]
28. Detection of poly(ADP-ribose) synthesis in Drosophila testes upon gamma-irradiation.
Lankenau S; Bürkle A; Lankenau DH
Chromosoma; 1999 Apr; 108(1):44-51. PubMed ID: 10199955
[TBL] [Abstract][Full Text] [Related]
29. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
30. ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method.
Daniels CM; Ong SE; Leung AKL
Methods Mol Biol; 2017; 1608():79-93. PubMed ID: 28695505
[TBL] [Abstract][Full Text] [Related]
31. Quantitative correlation between cellular proliferation and nuclear poly (ADP-ribose) polymerase (PARP-1).
Kun E; Kirsten E; Bauer PI; Ordahl CP
Int J Mol Med; 2006 Feb; 17(2):293-300. PubMed ID: 16391829
[TBL] [Abstract][Full Text] [Related]
32. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
[TBL] [Abstract][Full Text] [Related]
33. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
34. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism.
Bakondi E; Bai P; Erdélyi K; Szabó C; Gergely P; Virág L
Exp Dermatol; 2004 Mar; 13(3):170-8. PubMed ID: 14987257
[TBL] [Abstract][Full Text] [Related]
35. [Biological activity of poly(ADP-ribose)polymerase-1].
Kiliańska ZM; Zołnierczyk J; Wesierska-Gadek J
Postepy Hig Med Dosw (Online); 2010 Jul; 64():344-63. PubMed ID: 20679690
[TBL] [Abstract][Full Text] [Related]
36. A ribose-functionalized NAD
Zhang XN; Cheng Q; Chen J; Lam AT; Lu Y; Dai Z; Pei H; Evdokimov NM; Louie SG; Zhang Y
Nat Commun; 2019 Sep; 10(1):4196. PubMed ID: 31519936
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribose): PARadigms and PARadoxes.
Bürkle A; Virág L
Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of poly-adenosine diphosphate-ribosylation in human hepatocellular carcinoma.
Nomura F; Yaguchi M; Togawa A; Miyazaki M; Isobe K; Miyake M; Noda M; Nakai T
J Gastroenterol Hepatol; 2000 May; 15(5):529-35. PubMed ID: 10847440
[TBL] [Abstract][Full Text] [Related]
39. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM
Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribosyl)ation as a new posttranslational modification of YB-1.
Alemasova EE; Pestryakov PE; Sukhanova MV; Kretov DA; Moor NA; Curmi PA; Ovchinnikov LP; Lavrik OI
Biochimie; 2015 Dec; 119():36-44. PubMed ID: 26453809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
